By leveraging a reversed allosteric strategy to uncover the cryptic site Pocket Z, JYQ-42 not only achieves the selective inhibition of SIRT6 but also significantly curtails cancer cell migration and pro-inflammatory cytokine production, both of which are pivotal in the metastatic cascade. This evidence concerns the gene SIRT6 and cancer.